Back
Maze Therapeutics, Inc. Stock Predictions
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
64
MAZE
Maze Therapeutics, Inc.
Last Price:
$42.58
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiMaze Therapeutics, Inc. Stock Forecast
-
Is Maze Therapeutics, Inc. Stock Undervalued?The current Maze Therapeutics, Inc. [MAZE] share price is $42.60. The Score for MAZE is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
MAZE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Maze Therapeutics, Inc. Stock Go Up Next Year?
Data Unavailable
Maze Therapeutics, Inc. Stock Rating
Data Unavailable
Maze Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Sector:
Type:
stock
Website:
mazetx.com
52-Week Data
52-Week High:
43.29
52-Week Low:
6.71
Prediction Charts
Market Cap:
2B
Price in USD:
42.60
Volume:
516.9K
Beta:
4.99
Technical Analysis
SMA50:
31.44
SMA100:
24.08
SMA200:
17.58
52-Wk Change:
0%
Stock Predictions
-
Is Maze Therapeutics, Inc. stock public?Yes, Maze Therapeutics, Inc. is a publicly traded company.
-
What is the Maze Therapeutics, Inc. stock quote today?The Maze Therapeutics, Inc. stock price is 42.60 USD today.
-
How to buy Maze Therapeutics, Inc. stock online?You can buy Maze Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 31.99 | 32.53 | 33.76 | 31.63 |
| Nov-17 | 32.52 | 33.53 | 34.73 | 32.38 |
| Nov-18 | 33.06 | 33.23 | 34.12 | 32.35 |
| Nov-19 | 32.90 | 35.54 | 36.50 | 31.47 |
| Nov-20 | 36.04 | 35.57 | 37.23 | 35.48 |
| Nov-21 | 35.00 | 36.26 | 36.99 | 34.44 |
| Nov-24 | 36.99 | 36.66 | 37.44 | 36.23 |
| Nov-25 | 37.01 | 36.70 | 37.01 | 35.93 |
| Nov-26 | 36.70 | 38.00 | 38.49 | 36.48 |
| Nov-28 | 37.87 | 37.75 | 38.85 | 37.00 |
| Dec-1 | 37.66 | 37.60 | 38.39 | 36.90 |
| Dec-2 | 37.60 | 37.27 | 37.88 | 36.84 |
| Dec-3 | 37.89 | 41.49 | 41.88 | 37.45 |
| Dec-4 | 41.70 | 42.60 | 43.29 | 40.88 |
Maze Therapeutics, Inc. Earnings
Data Unavailable
Maze Therapeutics, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $16.95 per share, and a decrease next year of $0.05 per share.
* Maze Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.